Minimally Invasive Prostate Surgery Navigation System— 510(k) K221499

Name: FDA 510(k) clearance K221499
Creator: U.S. Food and Drug Administration
Published: 2022-11-22

Substantially Equivalent

Augment Intelligent Medical System (China) Co., Ltd.

FDA 510(k) clearance K221499 for Minimally Invasive Prostate Surgery Navigation System, Substantially Equivalent on 2022-11-22. Applicant: Augment Intelligent Medical System (China) Co., Ltd.. Device class: 2.

Clearance details

Applicant: Augment Intelligent Medical System (China) Co., Ltd.
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2022-05-23
Decision date: 2022-11-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Nanjing, CN

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

More clearances from Augment Intelligent Medical System (China) Co., Ltd.

view all

K242314 — Minimally Invasive Prostate Surgery Navigation System(Model:AmaKris SR1-A-2)2025-09-11

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.